Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507572 · ClinicalTrials.gov registry record
Collection of Outcomes Data for Pregnant Patients With Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 313
- Enrollment target
NCT00507572: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00507572 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 313 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507572 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 313 participants
- Enrollment target
Study Summary
This study collects treatment and outcomes information on pregnant patients who are or were pregnant with cancer. Gathering and storing health information on pregnant patients with cancer, may provide data for future research studies and improve patient care.
Interventions
- OTHER Medical Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2005-12-19 |
| Est. Completion | 2025-08-08 |
Why NCT00507572 stopped before completion
NCT00507572 is an observational study that tracks outcomes without assigning an intervention. The registered 313 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Medical Chart Review is the first listed.
NCT00507572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00507572 about?
NCT00507572 is a clinical study titled "Collection of Outcomes Data for Pregnant Patients With Cancer". This study collects treatment and outcomes information on pregnant patients who are or were pregnant with cancer. Gathering and storing health information on pregnant patients with cancer, may provide data for future research studies and improve patient care.
What is the current status of trial NCT00507572?
This trial is currently terminated. The enrollment target is 313 participants. The study started on 2005-12-19. Estimated completion is 2025-08-08.
What interventions are being tested in trial NCT00507572?
The interventions under investigation include: Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT00507572?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00595491 · 313 participants · Phase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI